CSIMarket Company Name, Ticker, Industry, else..
 
Evogene Ltd   (NASDAQ: EVGN)
 
Price: $0.5365 $-0.01 -2.455%
Day's High: $0.5498999953269958 Week Perf: -2.45 %
Day's Low: $ 0.51 30 Day Perf: 14.15 %
Volume (M): 158,554 52 Wk High: $ 1.50
Volume (M$): $ 0 52 Wk Avg: $0.89
Open: $0.55 52 Wk Low: $0.37



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 8
 Employees 31
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company develops discoveries and product candidates in agriculture, human health, and industrial applications, aiming to create commercially viable products that improve crop performance, provide clinical benefits, or enhance industrial inputs. It utilizes its CPB platform and technological engines, ChemPass AI and GeneRator AI, for research and development. The company collaborates with subsidiaries and partners to develop and commercialize these products, although most candidates have not yet reached commercialization.


   Company Address: 13 Gad Feinstein Street Rehovot 7638517
   Company Phone Number: 8-931-1900   Stock Exchange / Ticker: NASDAQ EVGN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Products & Services

Lavie Bio and Ceres Global Ag Corp. Pioneer Regenerative Agriculture in North America with YalosTM Bio-Inoculant

Published Wed, Mar 13 2024 1:00 PM UTC

In a groundbreaking collaboration, Lavie Bio Ltd., a subsidiary of Evogene Ltd., and Ceres Global Ag Corp. have joined forces to revolutionize regenerative agriculture in North America. Leveraging Lavie Bio s expertise in ag-biologicals and Ceres Global Ag s extensive knowledge in sustainable farming practices, the partnership aims to enhance soil health and productivity thr...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.10
Price to Sales (Expected) -
Price to Book 0.35
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.17
Working Capital Ratio 3.83
Leverage Ratio (MRQ) 0.67
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0 $
Revenues (TTM) 0.49 $
Cash Flow (TTM) -
Cash 1.65 $
Book Value 1.52 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 124,290
Net Income per Employee (TTM) -252,484
Receivable Turnover Ratio (TTM) 7.48
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.16

Profitability Ratios Current
Gross Margin (MRQ) -6.25 %
Operating Margin (MRQ) -364.24 %
Net Margin (MRQ) -203.14 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Evogene Ltd's Segments
Revenue Recognized At A Point In Time    65.38 % of total Revenue
Revenue Recognized Over Time    34.62 % of total Revenue
Agriculture    35.66 % of total Revenue
Industrial application    56.27 % of total Revenue
Unallocated    8.07 % of total Revenue
Customer A subsidiary shareholder    9.08 % of total Revenue
Customer B Member    22.84 % of total Revenue
Customer C Member    52.74 % of total Revenue
United States    0 % of total Revenue
Israel    0 % of total Revenue
Europe    0 % of total Revenue
Africa    0 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.